Elon Musk offers $1 million a day to entice swing state voters to sign petition
Tesla CEO and X owner Elon Musk, who supports Republican presidential nominee former U.S. President Donald Trump, gestures as he speaks about voting during an America PAC Town Hall in Folsom, Pennsylvania, U.S., October 17, 2024.
Rachel Wisniewski | Reuters
Elon Musk said Saturday that he would randomly award $1 million a day to registered voters who sign a petition for his pro-Trump political action committee in an effort to get his fans in swing states to the polls.
Speaking at an America PAC event in Harrisburg, Pennsylvania, Musk said, “I have a surprise for you,” adding that the prize money is available “every day from now until the election.”
Musk then called up a man named John Dreher, who he said was one of the petition signees in attendance, and handed him a giant check.
“I think think is kind of fun, and you know, it seems like a good use of money basically,” said the Tesla CEO, who is worth almost $250 billion.
Musk, who is also CEO of defense contractor SpaceX and owner of social media platform X, embarked on a speaking tour in Pennsylvania to drive voter registration in his support of the Republican nominee. He called the state the “linchpin” in this election.
“How Pennsylvania goes I think is how the election goes,” Musk said.
The deadline to sign the petition is Monday night, which is the day Pennsylvania’s voter registration closes. The petition, posted on the America PAC website, said that to be eligible for payments, signees “must be registered voters of Arizona, Georgia, Michigan, Nevada, North Carolina, Pennsylvania, or Wisconsin.”
Rick Hasen, a UCLA law professor and NBC news election law analyst, said in a blog post that Musk’s initiative appears to be a violation of federal election laws, specifically one that says a person who “pays or offers to pay or accepts payment either for registration to vote or for voting shall be fined not more than $10,000 or imprisoned not more than five years, or both.”
“Certain things in this country can be sold, and certain things we have decided should not be for sale,” Hasen told CNBC in an interview. “Congress has determined you should not be able to sell your vote to the highest bidder, and we should not have the political process distorted by people with the most wealth who may try to get you to vote in a certain way.”
CNBC reached out to Musk and one of his advisors for comment, but they didn’t respond.
In an interview with NBC’s “Meet the Press” on Sunday, Pennsylvania Democratic Gov. Josh Shapiro said Musk’s plan to give money to registered voters in his state is “deeply concerning” and “it’s something that law enforcement could take a look at.”
Floating conspiracy theories
At pro-Trump events, Musk has pushed debunked voter fraud conspiracies, called for deregulation, and repeatedly characterized President Biden and Vice President Kamala Harris, Trump’s rival, as replaceable “puppets.”
“No one’s even bothering to try to kill Kamala, you know, because there’s no point,” Musk said on Saturday, repeating a line he’s used in the past that caught the attention of the secret service. “I’m not suggesting someone should try to kill her, it would be pointless, but I’m just saying. I’m just making an observation.”
Musk said in his appearances that he views many government agencies and regulations in the U.S. as ineffective and unnecessary. Trump has taken up an idea floated by Musk to create a government efficiency commission, and said the tech magnate would be a big part of the commission.
“We should not trust the government, really. We just shouldn’t,” Musk said Harrisburg. “Even if I’m in the government, don’t trust the government.”
While Musk’s companies have long relied on government spending and support, he’s berated the Federal Communications Commission, the Environmental Protection Agency, Federal Aviation Administration and National Oceanic and Atmospheric Administration Fisheries for holding SpaceX back.
“We get crazy things,” Musk said, “like SpaceX got fined $140,000 for dumping potable drinking water on the ground at Starbase.”
As CNBC previously reported, SpaceX has repeatedly discharged hot, industrial wastewater into the wetlands surrounding the company’s launch pad in Boca Chica, Texas, which the EPA found was a Clean Water Act violation.
SpaceX Falcon Heavy rocket with the Clipper spacecraft sits on launch pad 39A before the launch at the Kennedy Space Center in Florida on October 14, 2024.
Chandan Khanna | Afp | Getty Images
Musk mocked NOAA Fisheries for asking SpaceX to conduct a study to predict how its rockets could impact sharks and whales if they fall into the ocean.
“I’m like, it’s a big ocean, you know, there’s a lot of sharks. It’s not impossible, but it’s very unlikely,” Musk said. The agency’s mission is to “conserve America’s coastal and marine resources.”
Musk’s animosity towards President Biden picked up in 2021, when the White House declined to invite Tesla to an electric vehicle summit.
“You know, Tesla’s about 140,000 people — it’s like there’s a lot of blood, sweat and tears from people working hard to make great electric cars,” Musk said on Saturday. “To be could-shouldered like that for no reason. It’s like, what’s the deal?”
Musk has long battled unions, and Tesla was charged with union-busting before the EV summit. Biden has maintained a pro-labor platform throughout his presidency.
One attendee in Harrisburg asked Musk if he believed that self-driving cars should eventually be mandatory if they can perform more safely in traffic than human drivers. Tesla has promised customers a “robotaxi” for years, but never produced one.
Musk suggested he was against anything federally mandated.
“We should just get the government out of things and let the market figure it out,” he said. “I’m generally against government. With that, I’d like to thank you all for coming. It’s been an honor to speak with you.”
Musk only mentioned Trump sparingly throughout the evening, and didn’t discuss his policies or record as president in any detail.
Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023.
Kelly Sullivan | Getty Images Entertainment | Getty Images
23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities and Exchange Commission.
Wojcicki and New Mountain have offered to acquire all of 23andMe’s outstanding shares in cash for $2.53 per share, or an equity value of approximately $74.7 million. The company’s stock closed at $2.42 on Friday with a market cap of about $65 million.
The offer comes after a turbulent year for 23andMe, with the stock losing more than 80% of its value in 2024. In January, the company announced plans to explore strategic alternatives, which could include a sale of the company or its assets, a restructuring or a business combination.
23andMe has a special committee of independent directors in place to evaluate potential paths forward. The company appointed three new independent directors to its board in October after all seven of its previous directors abruptly resigned the prior month. The special committee has to approve Wojcicki and New Mountain’s proposal.
“We believe that our Proposal provides compelling value and immediate liquidity to the Company’s public stockholders,” Wojcicki and Matthew Holt, managing director and president of private equity at New Mountain, wrote in a letter to the special committee on Thursday.
Wojcicki previously submitted a proposal to take the company private for 40 cents per share in July, but it was rejected by the special committee, in part because the members said it lacked committed financing and did not provide a premium to the closing price at the time.
Wojcicki and New Mountain are willing to provide secured debt financing to fund 23andMe’s operations through the transaction’s closing, the filing said. New Mountain is based in New York and has $55 billion of assets under management, according to its website.
23andMe declined to comment.
WATCH: The rise and fall of 23andMe
Hims & Hers
Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved.
Semaglutide is the active ingredient in Novo Nordisk‘s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies such as Hims & Hers have been prescribing compounded semaglutide as an alternative for patients who are navigating volatile supply hurdles and insurance obstacles.
Compounded drugs are custom-made alternatives to brand-name drugs designed to meet a specific patient’s needs, and compounders are allowed to produce them when brand-name treatments are in shortage. The FDA doesn’t review the safety and efficacy of compounded products.
Hims & Hers began offering compounded semaglutide to patients in May, and it owns compounding pharmacies that produce the medications.
Compounded medications are typically much cheaper than their branded counterparts. Hims & Hers sells compounded semaglutide for less than $200 per month, while Ozempic and Wegovy both cost around $1,000 per month without insurance.
The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days, depending on the type of facility, in order to “avoid unnecessary disruption to patient treatment.”
“Now that the FDA has determined the drug shortage for semaglutide has been resolved, we will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO Andrew Dudum posted Friday on X. “We’re also closely monitoring potential future shortages, as Novo Nordisk stated two weeks ago that it would continue to have ‘capacity limitations’ and ‘expected continued periodic supply constraints and related drug shortage notifications.'”
Him & Hers’ weight loss offerings have been a massive hit with investors. Shares of the company climbed more than 200% last year, and the stock is already up more than 100% this year despite Friday’s move.
Even before it added compounded GLP-1s to its portfolio, the company said in its 2023 fourth-quarter earnings call that it expects its weight loss program to bring in more than $100 million in revenue by the end of 2025.
Despite the turbulent regulatory landscape, Hims & Hers has showed no signs of slowing down.
On Friday, the company announced it has acquired a U.S.-based peptide facility that will “further verticalize the company’s long-term ability to deliver personalized medications.” Hims & Hers will explore advances across metabolic optimization, recovery science, biological resistances, cognitive performance and preventative health through the acquisition, the company said.
That move comes just days after Hims & Hers also bought Trybe Labs, the New Jersey-based at-home lab testing facility. Trybe Labs will allow Hims & Hers to perform at-home blood draws and more comprehensive pretreatment testing.
Hims & Hers did not disclose the terms of either deal.
Technology
Tesla recalls more than 375,000 vehicles in U.S. due to failing power-assisted steering systems
Tesla models Y and 3 are displayed at a Tesla dealership in Corte Madera, California, on Dec. 20, 2024.
Justin Sullivan | Getty Images
Tesla is voluntarily recalling 376,241vehicles in the U.S. to correct an issue with failing power-assisted steering systems, according to records posted to the website of the U.S. National Highway Traffic Safety Administration.
In a safety recall report posted on the NHTSA website, Tesla said the recall includes Model 3 and Model Y vehicles that were manufactured for sale in the U.S. from Feb. 28, 2023, to October 11, 2023, and that were equipped with a certain older software release.
The records said printed circuit boards in the steering systems in affected vehicles could become overstressed, causing the power-assist steering to fail in some cases when a Tesla vehicle rolled to a stop and then accelerated.
When electronic power-assist steering systems fail in a Tesla, drivers need to exert more force to steer their cars, which can increase the risk of a collision.
Tesla told the vehicle safety regulator that it was not aware of any crashes, injuries or deaths related to the power steering failures, and that it was offering an over-the-air software update as a remedy.
The recall follows an earlier related probe and voluntary recall in China concerning the same systems.
President Donald Trump has appointed Tesla CEO Elon Musk to lead a team that is slashing the federal government workforce, and in some cases, regulations and entire agencies. Those cuts already affected the NHTSA, an agency Musk has long seen as standing in the way of some of his ambitions at Tesla.
The regulator has been engaged in a yearslong investigation into safety defects in the systems that Tesla markets currently as its Autopilot and Full Self-Driving (Supervised) options. The features do not make Tesla cars into robotaxis. They require a human driver ready to steer or brake at any time.
The Washington Post reported on Thursday that Musk’s team has led mass firings at the NHTSA, reducing the agency’s workforce and capacity to investigate companies including Tesla by about 10%.
Tesla didn’t respond to a request for comment.
-
Sports2 years ago‘Storybook stuff’: Inside the night Bryce Harper sent the Phillies to the World Series
-
Sports11 months agoStory injured on diving stop, exits Red Sox game
-
Sports1 year agoGame 1 of WS least-watched in recorded history
-
Sports2 years agoMLB Rank 2023: Ranking baseball’s top 100 players
-
Sports3 years ago
Team Europe easily wins 4th straight Laver Cup
-
Environment2 years agoJapan and South Korea have a lot at stake in a free and open South China Sea
-
Environment2 years agoGame-changing Lectric XPedition launched as affordable electric cargo bike
-
Business2 years agoBank of England’s extraordinary response to government policy is almost unthinkable | Ed Conway